Financial results - OVVA PHARMACEUTICAL S.R.L.

Financial Summary - Ovva Pharmaceutical S.r.l.
Unique identification code: 43606400
Registration number: J2021000076372
Nace: 4775
Sales - Ron
42.856
Net Profit - Ron
13.588
Employees
1
Open Account
Company Ovva Pharmaceutical S.r.l. with Fiscal Code 43606400 recorded a turnover of 2024 of 42.856, with a net profit of 13.588 and having an average number of employees of 1. The company operates in the field of Comerţ cu amănuntul al produselor cosmetice şi de parfumerie having the NACE code 4775.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Ovva Pharmaceutical S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - - - 17.056 7.510 48.420 42.856
Total Income - EUR - - - - - - 17.056 7.510 48.420 42.700
Total Expenses - EUR - - - - - - 16.519 21.054 47.489 25.537
Gross Profit/Loss - EUR - - - - - - 538 -13.544 931 17.163
Net Profit/Loss - EUR - - - - - - 367 -13.654 444 13.588
Employees - - - - - - 0 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -11.0%, from 48.420 euro in the year 2023, to 42.856 euro in 2024. The Net Profit increased by 13.147 euro, from 444 euro in 2023, to 13.588 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Ovva Pharmaceutical S.r.l.

Rating financiar

Financial Rating -
OVVA PHARMACEUTICAL S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Ovva Pharmaceutical S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Ovva Pharmaceutical S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Ovva Pharmaceutical S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Ovva Pharmaceutical S.r.l. - CUI 43606400

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - - - 1.672 1.454 1.227 998
Current Assets - - - - - - 38.514 33.762 29.739 12.479
Inventories - - - - - - 19.612 22.364 10.183 2.373
Receivables - - - - - - 17.846 9.944 9.924 8.802
Cash - - - - - - 1.056 1.454 9.632 1.304
Shareholders Funds - - - - - - 408 -13.245 -12.762 898
Social Capital - - - - - - 40 41 40 40
Debts - - - - - - 39.779 48.461 43.727 12.578
Income in Advance - - - - - - 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4775 - 4775"
CAEN Financial Year 2120
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 12.479 euro in 2024 which includes Inventories of 2.373 euro, Receivables of 8.802 euro and cash availability of 1.304 euro.
The company's Equity was valued at 898 euro, while total Liabilities amounted to 12.578 euro. Equity increased by 13.588 euro, from -12.762 euro in 2023, to 898 in 2024.

Risk Reports Prices

Reviews - Ovva Pharmaceutical S.r.l.

Comments - Ovva Pharmaceutical S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.